Expression, purification and application of a recombinant, membrane permeating version of the light chain of botulinum toxin B.
TL;DR
A recombinant version of BoNT/B that consists of the light chain of the toxin fused to the protein transduction domain of the human immunodeficiency virus-1 (TAT peptide) and a hexahistidine tag is generated that disrupts the function of a SNARE protein within minutes in cells that may or may not express the receptors for the BoNT/B heavy chain.
OpenAlex 토픽 ·
Botulinum Toxin and Related Neurological Disorders
Neurological disorders and treatments
Hereditary Neurological Disorders
A recombinant version of BoNT/B that consists of the light chain of the toxin fused to the protein transduction domain of the human immunodeficiency virus-1 (TAT peptide) and a hexahistidine tag is ge
APA
Micaela Vanina Buzzatto, Fabiana Cristina Benegas Guerrero, et al. (2024). Expression, purification and application of a recombinant, membrane permeating version of the light chain of botulinum toxin B.. Bioscience reports, 44(7). https://doi.org/10.1042/BSR20240117
MLA
Micaela Vanina Buzzatto, et al.. "Expression, purification and application of a recombinant, membrane permeating version of the light chain of botulinum toxin B.." Bioscience reports, vol. 44, no. 7, 2024.
PMID
39011584
Abstract
Botulinum neurotoxins (BoNTs) are valuable tools to unveil molecular mechanisms of exocytosis in neuronal and non-neuronal cells due to their peptidase activity on exocytic isoforms of SNARE proteins. They are produced by Clostridia as single-chain polypeptides that are proteolytically cleaved into light, catalytic domains covalently linked via disulfide bonds to heavy, targeting domains. This format of two subunits linked by disulfide bonds is required for the full neurotoxicity of BoNTs. We have generated a recombinant version of BoNT/B that consists of the light chain of the toxin fused to the protein transduction domain of the human immunodeficiency virus-1 (TAT peptide) and a hexahistidine tag. His6-TAT-BoNT/B-LC, expressed in Escherichia coli and purified by affinity chromatography, penetrated membranes and exhibited strong enzymatic activity, as evidenced by cleavage of the SNARE synaptobrevin from rat brain synaptosomes and human sperm cells. Proteolytic attack of synaptobrevin hindered exocytosis triggered by a calcium ionophore in the latter. The novel tool reported herein disrupts the function of a SNARE protein within minutes in cells that may or may not express the receptors for the BoNT/B heavy chain, and without the need for transient transfection or permeabilization.
추출된 의학 개체 (NER)
| 유형 | 영어 표현 | 한국어 / 풀이 | UMLS CUI | 출처 | 등장 |
|---|---|---|---|---|---|
| 시술 | botulinum toxin
|
보툴리눔독소 주사 | dict | 1 | |
| 해부 | membrane
|
scispacy | 1 | ||
| 해부 | neuronal
|
scispacy | 1 | ||
| 해부 | non-neuronal cells
|
scispacy | 1 | ||
| 해부 | membranes
|
scispacy | 1 | ||
| 해부 | cells
|
scispacy | 1 | ||
| 약물 | permeating
|
scispacy | 1 | ||
| 약물 | BoNTs
→ Botulinum neurotoxins
|
C0006055
Botulinum Toxins
|
scispacy | 1 | |
| 약물 | disulfide
|
C0012771
Disulfides
|
scispacy | 1 | |
| 약물 | calcium ionophore
|
C0444420
Calcium Ionophores
|
scispacy | 1 | |
| 약물 | calcium
|
scispacy | 1 | ||
| 질환 | neurotoxicity
|
C0235032
Neurotoxicity Syndromes
|
scispacy | 1 | |
| 질환 | human immunodeficiency virus-1
|
C0019682
HIV
|
scispacy | 1 | |
| 질환 | His6-TAT-BoNT/B-LC
|
scispacy | 1 | ||
| 기타 | SNARE
|
scispacy | 1 | ||
| 기타 | single-chain
|
scispacy | 1 | ||
| 기타 | BoNTs
→ Botulinum neurotoxins
|
scispacy | 1 | ||
| 기타 | BoNT/B
|
scispacy | 1 | ||
| 기타 | human immunodeficiency virus-1
|
scispacy | 1 | ||
| 기타 | TAT peptide
|
scispacy | 1 | ||
| 기타 | Escherichia coli
|
scispacy | 1 | ||
| 기타 | SNARE synaptobrevin
|
scispacy | 1 | ||
| 기타 | rat brain synaptosomes
|
scispacy | 1 | ||
| 기타 | human sperm cells
|
scispacy | 1 | ||
| 기타 | synaptobrevin
|
scispacy | 1 |
MeSH Terms
Animals; Humans; Rats; Botulinum Toxins, Type A; Exocytosis; SNARE Proteins; Male; Synaptosomes; Escherichia coli; Recombinant Fusion Proteins; Recombinant Proteins; Cell Membrane Permeability; Botulinum Toxins
🔗 함께 등장하는 도메인
이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들
관련 논문
- Local therapeutic strategies for neurocutaneous dysesthesia: from capsaicin to cannabinoids.
- Comparative efficacy of intralesional therapies for keloid scars: a network meta-analysis.
- Adverse neurological events following botulinum toxin type A: A case series of post-injection seizures and paralysis.
- Decreased utilization of component separation techniques over time in complex abdominal wall reconstruction following introduction of preoperative botulinum toxin A.
- Current Perspectives on Pectoralis Minor Syndrome: A Narrative Review.